Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases

被引：0
|
作者：
Parth Shah
机构：
[1] ObvioHealth,
来源：
Current Cardiology Reports | 2018年 / 20卷
关键词：
Alirocumab; Evolocumab; PCSK9; Cardiovascular; Cholesterol; Lipoprotein (a);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases
    Shah, Parth
    CURRENT CARDIOLOGY REPORTS, 2018, 20 (07)
  • [2] PCSK9 INHIBITORS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
    Knijnik, Leonardo M.
    Rivera, Manuel
    Cardoso, Rhanderson
    Fernandes, Gilson
    Fernandes, Amanda
    Orringer, Carl
    Cohen, Mauricio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 41 - 41
  • [3] PCSK9 inhibitors in the prevention of cardiovascular disease
    James Latimer
    Jonathan A. Batty
    R. Dermot G. Neely
    Vijay Kunadian
    Journal of Thrombosis and Thrombolysis, 2016, 42 : 405 - 419
  • [4] A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases
    Chen, Bo
    Shi, Xin
    Cui, Yanping
    Hou, Aiping
    Zhao, Pengjun
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (20) : 1790 - 1817
  • [5] PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease
    Bittner, Vera A.
    Giugliano, Robert P.
    Brinton, Eliot A.
    Guyton, John R.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (04) : 835 - 843
  • [6] Novel PCSK9 Inhibitors for Treating Cardiovascular Diseases
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (04): : 443 - 444
  • [7] PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention
    Paciullo, Francesco
    Momi, Stefania
    Gresele, Paolo
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (03) : 359 - 367
  • [8] Effects of PCSK9 inhibitors on cancer, diabetes, and cardiovascular diseases
    Nejabat, Mojgan
    Hadizadeh, Farzin
    Almahmeed, Wael
    Sahebkar, Amirhossein
    DRUG DISCOVERY TODAY, 2025, 30 (03)
  • [9] PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
    Marco-Benedi, Victoria
    Sanchez-Hernandez, Rosa M.
    Diaz, Jose Luis
    Jarauta, Estibaliz
    Suarez-Tembra, Manuel
    Pinto, Xavier
    Morillas, Carlos
    Plana, Nuria
    Pedro-Botet, Juan
    Civeira, Fernando
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [10] Incorporation of PCSK9 inhibitors into prevention of atherosclerotic cardiovascular disease
    Wojcik, Cezary
    POSTGRADUATE MEDICINE, 2017, 129 (08) : 801 - 810
12345